HEALTH TECHNOLOGY

Medidata Announces Expansion with the Addition of 10 Tech Innovators to its Sensor Cloud Network

Medidata and Dassault Systèmes | June 30, 2022

Medidata Announces

Ten incredibly inventive companies have joined Medidata's ground-breaking Sensor Cloud Network, according to the Dassault Systèmes firm. The first cross-sector partnership is now made up of AliveCor, Aural Analytics, Biobeat, Blue Spark Technologies, Glooko, Indie Health, University of Arizona, Carnegie Mellon University, University of Rochester, and University of Vermont. Its goals include resolving issues with sensor integration, standardizing sensor data, and creating new digital biomarkers and algorithms. These will contribute to the development of new digital endpoints that might lead to the development of more potent therapies and improved patient care.

The Sensor Cloud Network offers data scientists the chance to develop, test, and deliver physiological algorithms with clinical relevance at scale. The network consists of contract research organizations (CROs), device manufacturers, drug and vaccine developers, analytics firms, and academic institutions. Detailed motion characteristics including gait, cardiovascular measures, metabolic insights, and voice analytics of the highest caliber are a few examples.

As the use of sensors in clinical trials is predicted to reach 50% by 20251, we are focused on making Medidata Sensor Cloud the industry standard for collecting and analyzing medical-grade sensor data. “We are excited to work with a diverse group of partners to help shape the future of patient data collection and analysis, and make Sensor Cloud the platform of choice for developing new digital biomarkers across a wide variety of therapeutic areas.”

Ben Schlatka, Vice President, Digital Biomarker Solutions, Medidata
 

Spotlight

In the world of nature, metamorphosis is the development process that many insects experience on their way to full maturity. These complex creatures typically originate in the form of an egg, with low level sophistication. They then migrate into a nymph, a middle stage of development, and later are considered adult, with fully developed systems that help the insect adapt, survive and fulfill their purpose in the ecosystem.

Spotlight

In the world of nature, metamorphosis is the development process that many insects experience on their way to full maturity. These complex creatures typically originate in the form of an egg, with low level sophistication. They then migrate into a nymph, a middle stage of development, and later are considered adult, with fully developed systems that help the insect adapt, survive and fulfill their purpose in the ecosystem.

Related News

HEALTH TECHNOLOGY

MedNetOne Health Solutions Is the First Physician Organization in Michigan to Have a Joint Venture with Honest Medical Group

Honest Medical Group | June 13, 2022

MedNetOne Health Solutions announced it is the first Michigan physician organization to enter into a joint venture with Nashville-based Honest Medical Group, a physician enablement company aimed at improving the health care experience and reducing costs for members with Medicare Advantage. The announcement was made by MedNetOne co-founders Ewa Matuszewski, CEO, and Al Juocys, D.O., President and Chief Medical Officer. It follows Blue Cross Blue Shield of Michigan's announcement that it would form a joint venture with Honest Medical Group to facilitate independent joint ventures between physician groups such as MedNetOne and Honest Medical Group for risk and revenue sharing. "This is a huge step in the right direction for Medicare Advantage providers and their patients. Transforming primary care is no longer a dream – it's a reality. And we could not be more excited about where the partnership will take us for the benefit of patients." Dr. Aric Coffman, CEO of Honest Medical Group MedNetOne has been tightly connected with payors focusing on innovative, patient-centered quality care programs and its capacity to meet quality performance measures reliably. This emphasis encouraged the company to seek a partnership with the Honest Medical Group earnestly. MedNetOne provides a wide range of services to independent medical practices, advanced practice physicians, mental health specialists, and chiropractors that are intent on running fully integrated, population-based, patient-centric practices with modern technological infrastructure. In addition, 18% of the population served is at least 65 years old and qualified for or enrolled in a Medicare Advantage plan. The company tests, develops, and implements novel care management techniques and expanded multidisciplinary team care services, emphasizing providing care for the complete person to people with chronic illnesses such as diabetes, hypertension, obesity, chronic pain, and asthma. Additionally, the company has expanded its offerings to include palliative care. During the pandemic, MedNetOne established 120 vaccination clinics in schools and ethnic areas and is a partner of the Detroit Equity Coalition on Covid-19. The organization has recently launched a mobile clinic for community-based treatment, particularly in marginalized regions, to provide primary care services such as chronic illness care, physicals, blood pressure screenings, and immunizations.

Read More

FUTURE OF HEALTHCARE

Solera Health Teams Up With DarioHealth to Offer Hypertension Solutions

Solera Health | June 16, 2022

Leading personalized health solutions platform, Solera Health announced that it has added DarioHealth to its cardiometabolic network to offer hypertension management solutions. "Chronic conditions like hypertension can be difficult to manage, especially when in conjunction with multiple other diseases or symptoms. According to the CDC, nearly half of adults in the U.S. experience high blood pressure, and the prevalence increases with age. We are thrilled to expand Solera's offerings to patients with this condition through our partnership with Dario, as well as continue strengthening relationships with our health plan partners by empowering them to offer accessible, best-in-class digital health solutions." Mary Langowski, CEO, Solera Cardiometabolic conditions comprise both cardiovascular and metabolic disorders such as hypertension, diabetes, and obesity. Dario delivers a personalized solution through the use of medical devices, next-generation technologies, and smartphone applications in order to boost customers’ commitment to healthy living. "We are excited to partner with Solera and share our digital hypertension solutions with their payer and employer clients. Dario is committed to improving access and quality of care for individuals with hypertension by expanding the reach of our highly personalized solutions. This collaboration with Solera expands our ability to reach patients and continue our mission of transforming care for people with chronic conditions." Rick Anderson, President & General Manager, North America of DarioHealth

Read More

FUTURE OF HEALTHCARE

Jvion AI and SDoH Solutions Acquired by Lightbeam

Lightbeam Health Solutions, Inc., | June 01, 2022

Lightbeam Health Solutions Inc., an organization at the forefront of population health management, announced that it has signed an asset purchase agreement to acquire Jvion, Inc., and the firm’s cutting-edge, AI-enabled social determinants of health (SDoH) solutions. “Together, Lightbeam and Jvion’s technologies will bring critical, proactive, and scalable insights to populations across all types of value-based care models. The Jvion team believes strongly in the purpose and promise of our integrated offerings, and I am excited for the Jvion team to begin this next chapter with Lightbeam.” Tom Zajac, Executive Chairman of Jvion The acquisition is a strategic move for Lightbeam considering Jvion’s client base will be able to access CareSignal and other advanced range of Deviceless Remote Patient Monitoring® (RPM) programs. They are known to improve clinical processes and decrease utilization across patient populations. The acquisition is aimed at benefiting Jvion clients by boosting the value of its existing solution. The agreement will cement the position of the combined partnership as a front runner in population health management through a well-designed product offering that includes the following Data Aggregation and Analytics that seamlessly integrates clinical workflows, organizes risk stratification, and coverts insights into results Predictive Models and AI that can predict patient risk and jumpstart clinical intervention Deviceless Remote Patient Monitoring improves staffing efficiency by delivering patient screening and care management to patients regardless of where they are in the care journey For current Jvion customers and partners, your success is our success. The breadth and timeliness of the combined technology and services will extend fully, and as a top priority, to our clients and partners. Pat Cline, CEO of Lightbeam

Read More